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Editors: Anton N. Sidawy and Bruce A. PerlerOutcome of the pivotal study of the Aptus endovascular
abdominal aortic aneurysms repair system
Manish Mehta, John Henretta, Marc Glickman, David
Deaton, Thomas C. Naslund, Bruce Gray, Richard McCann,
William Jordan, Ronald Fairman
Objective: Endovascular treatment of abdominal aortic
aneurysm (AAA) is associated with beneﬁts over open sur-
gery, yet limitations remain with current endovascular
devices. This study was performed to assess outcomes of
AAA repair with the Aptus endograft and EndoAnchors
(Aptus Endosystems, Sunnyvale, Calif).
Methods: This prospective, multicenter, single-arm inves-
tigational device exemption trial was conducted at 25 sites
in the United States. A total of 155 patients were enrolled in
the trial (mean age, 73  8 years; male, 93.5%; mean AAA
diameter, 53.6  7.9 mm). The Aptus endograft is a two-
component system: a multilumen, modular endograft with
two docking limbs (Aptus Endograft System) and the Heli-FX
Aortic Securement System comprising an electronically
controlled applier (Heli-FX Applier) with helical EndoAn-
chors provided in a cassette and a deﬂectable sheath (Heli-
FX Guide) designed for delivery of the applier to the target
location for EndoAnchor implantation. The main eligibility
criteria included proximal neck length of 12 mm, diameter
of 19 to 29 mm, and infrarenal angulation of 60 degrees.
The primary safety end point was freedom from major
adverse events at 30 days, and the primary effectiveness
end point was successful aneurysm treatment at 12
months. Thrombus-related events (TRE) were deﬁned as
limb occlusion or thromboembolism from the endograft.
Subjects were observed for a median of 4.2 years, with
imaging end points analyzed by a core laboratory and
adverse events adjudicated by a clinical events committee.
Results: Among 155 enrolled subjects, 153 (98.7%) under-
went successful implantation of the Aptus endograft and a
median of ﬁve EndoAnchors; two subjects were converted
to open surgical repair during the initial procedure. Overall,
the primary safety and effectiveness end points were met in
98.1% and 97.4% of the subjects, respectively. Aneurysm-
related mortality was 0.6%, with one postdischarge cardiac
death 18 days after implantation. There were no AAA rup-
tures. There were no fractures of stents or EndoAnchors.
There was one type I endoleak and one type III endoleak.
Stent graft migration was noted in ﬁve subjects, none
associated with sac enlargement, type I endoleak, or*Full articles available online at www.jvascsurg.org
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shrinkage of 5 mm at 1, 2, and 3 years was observed in
60.3%, 72.9%, and 81.7%, respectively. Sixty-one subjects
(39.4%) experienced 113 TRE, associated with 80 reinter-
ventions (in 58 subjects) unassociated with limb loss or
death. A root cause analysis of TRE identiﬁed small, out-of-
speciﬁcation docking limbs with graft infolding and high
local shear, resulting in thrombus formation within the
endograft with subsequent distal embolization in some
cases.
Conclusions: Early results of the Aptus endograft trial met its
safety and effectiveness end points; however, a high rate of
TRE was observed because of manufacturing discrepancies.
The ﬁndings conﬁrm a low rate of type I and type III endo-
leaks, migration, and non-TRE reintervention with a high rate
of aneurysm sac regression during midterm follow-up.Elective endovascular aortic repair conversion for type Ia
endoleak is not associated with increased morbidity or
mortality compared with primary juxtarenal aneurysm
repair
Salvatore T. Scali, Michael M. McNally, Robert J. Feezor,
Catherine K. Chang, Alyson L. Waterman, Scott A. Berceli,
Thomas S. Huber, Adam W. Beck
Objective: Type Ia endoleak after endovascular aortic repair
(EVAR) can be a challenging complication to manage, and
due to concerns regarding morbidity and mortality of open
surgical conversion (OSC), reports of complex endoluminal
salvage techniques are increasing. Despite development of
these endovascular remedial strategies, many patients
ultimately require OSC. The purpose of this analysis was to
outcomes of elective OSC for type Ia endoleak and compare
them with elective primary open juxtarenal aneurysm repair
(OJAR) to determine if these concerns are warranted.
Methods: From 2000 to 2012, 54 patients underwent EVAR
OSC at median time of 27 months (interquartile range, 9-55
months). Indications included endograft thrombosis in 2
(4%), intraoperative EVAR failure in 3 (6%), rupture in 5
(9%), graft infection in 6 (11%), and type Ia endoleak in 25
(all: 38 [70%]). Because many OSCs are performed for
emergency indications without endovascular options, we
chose elective type Ia endoleak patients as our study group.
These 25 patients were compared with an elective OJAR
cohort matched by anatomy and comorbidities. Primary
end points were 30-day and 1-year mortality. Secondary
end points included early complications, cross-clamp time,
procedure time, blood loss, and length of stay.
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OJAR groups did not differ, with the exception that OJAR
patients presented with smaller aneurysm diameter and a
higher rate of chronic obstructive pulmonary disease (P =
.03). OSC patients more frequently underwent a nontube
graft repair (OSC, n = 20 [80%] vs OJAR, n = 6 [24%]; P =
.0002), required longer procedure times (P = .03), and
received more plasma transfusions (P = .03). The 30-day
mortality was 4% in both groups (observed difference in
rates, 0%; 95% conﬁdence interval for difference in mor-
tality rates, â 14.0% to 14.0%; P = 1). A similar rate of major
complications occurred (OSC, n = 9 [36%] vs OJAR, n = 8
[32%]; P = 1). One-year survival was 83% in OSC and 91% in
OJAR (observed difference, 7%; 95% conﬁdence interval,
â 15% to 29%; P = .65).
Conclusions: Despite many advances in EVAR technology,
the need for OSC persists and will likely become more
common as older-generation devices fail or providers
attempt EVAR in more anatomically complex patients.
Elective OSC for type Ia endoleak can be technically chal-
lenging but is not associated with increased morbidity or
mortality compared with OJAR in appropriately selected
patients. These results should be considered before pursu-
ing complex endovascular remediation of EVAR failures.Postapproval outcomes of juxtarenal aortic aneurysms
treated with the Zenith fenestrated endovascular graft
Chandu Vemuri, Gustavo S. Oderich, Jason T. Lee, Mark A.
Farber, Andres Fajardo, Edward Y. Woo, Neal Cayne, Luis A.
Sanchez
Objective: The objective of this study was to evaluate
postapproval outcomes of patients with juxtarenal aortic
aneurysms treated with the Zenith fenestrated endovas-
cular graft (Cook Inc, Bloomington, Ind).
Methods: We reviewed clinical data of consecutive patients
treated with the Zenith fenestrated endovascular graft in
the United States at seven institutions with early commer-
cial access from July 2012 to December 2012. Clinical out-
comes and compliance to anatomic guidelines were
compared with results of the U.S. fenestrated trial (USFT).
Results: Fifty-seven patients were treated. There were sig-
niﬁcantly more (P < .05) patients with coronary artery
disease, myocardial infarction, and preoperative renal
insufﬁciency than in the USFT. Thirty-six patients (63.2%) did
not meet the USFT anatomic criteria of a >4-mm infrarenal
neck, and there were signiﬁcantly more mesenteric stents
(13 vs 0; P < .05) used in this group than in the USFT,
reﬂecting the higher anatomic complexity of these patients.
The total operative time was 250.2  14.8 minutes, the
ﬂuoroscopy time was 68.9  4.47 minutes, and the average
volume of contrast material was 108.6  5.6 mL. Technical
success was 100% in regard to aneurysm exclusion,
although the left renal fenestration was not able to bealigned in two patients, and one patient had a kinked renal
stent that was successfully restented. During this time
period, there were a total of 10 endoleaks, of which two
were type III and eight were type II.
Conclusions: Despite higher rates of comorbidities and
more challenging anatomy, early 30-day outcomes of jux-
tarenal aortic aneurysms treated postapproval with the
Zenith fenestrated endovascular graft compare well with
USFT data. Future studies are needed to assess durability of
this treatment modality as the technology diffuses and data
mature.Dutch experience with the fenestrated Anaconda
endograft for short-neck infrarenal and juxtarenal
abdominal aortic aneurysm repair
Martijn L. Dijkstra, Ignace F.J. Tielliu, Robbert Meerwaldt,
Maurice Pierie, Jerome van Brussel, Geert Willem H.
Schurink, Jan-Willem Lardenoye, Clark J. Zeebregts
Objective: In the past decennium, the management of
short-neck infrarenal and juxtarenal aortic aneurysms with
fenestrated endovascular aneurysm repair (FEVAR) has
been shown to be successful, with good early and midterm
results. Recently, a new fenestrated device, the fenestrated
Anaconda (Vascutek, Renfrewshire, Scotland), was intro-
duced. The aim of this study was to present the current
Dutch experience with this device.
Methods: A prospectively held database of patients treated
with the fenestrated Anaconda endograft was analyzed.
Decision to treat was based on current international
guidelines. Indications for FEVAR included an abdominal
aortic aneurysm (AAA) with unsuitable neck anatomy for
EVAR. Planning was performed on computed tomography
angiography images using a three-dimensional workstation.
Results: Between May 2011 and September 2013, 25
patients were treated in eight institutions for juxtarenal (n =
23) and short-neck AAA (n = 2). Median AAA size was 61
mm (59-68.5 mm). All procedures except one were per-
formed with bifurcated devices. A total of 56 fenestrations
were incorporated, and 53 (94.6%) were successfully can-
nulated and stented. One patient died of bowel ischemia
caused by occlusion of the superior mesenteric artery. On
completion angiography, three type I endoleaks and seven
type II endoleaks were observed. At 1 month of follow-up,
all endoleaks had spontaneously resolved. Median follow-
up was 11 months (range, 1-29 months). There were no
aneurysm ruptures or aneurysm-related deaths and no
reinterventions to date. Primary patency at 1 month of
cannulated and stented target vessels was 96%.
Conclusions: Initial and short-term results of FEVAR using
the fenestrated Anaconda endograft are promising, with
acceptable technical success and short-term complication
rates. Growing experience and long-term results are needed
to support these ﬁndings.
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management of ruptured aortic aneurysms
Elliott M. Groves, Mahdi Khoshchehreh, Christine Le,
Shaista Malik
Objective: Ruptured aortic aneurysm is a condition with a
high rate of mortality that requires prompt surgical inter-
vention. It has been noted that in some conditions requiring
such prompt intervention, in-hospital mortality is increased
in patients admitted on the weekends compared with
patients admitted on weekdays. We sought to determine if
this was indeed the case for both ruptured thoracic aortic
aneurysms (TAA) and abdominal aortic aneurysms (AAA)
and to elucidate the possible reasons.
Methods: Using the Nationwide Inpatient Sample, a pub-
licly available database of inpatient care, we analyzed the
incidence of mortality among 7200 patients admitted on
the weekends compared with weekdays for ruptured aortic
aneurysm. Among these patients, 19% had a TAA and 81%
had an AAA, and each group was analyzed for differences in
mortality during the hospitalization. We adjusted for dem-
ographics, comorbid conditions, hospital characteristics,
rates of surgical intervention, timing of surgical inter-
vention, and use of additional therapeutic measures.
Results: Patients admitted on the weekend for both rup-
tured TAA and AAA had a statistically signiﬁcant increase in
mortality compared with those admitted on the weekdays
(TAA: odds ratio, 2.55; 95% conﬁdence interval, 1.77-3.68; P
= .03; AAA: odds ratio, 1.32; 95% conﬁdence interval, 1.13-
1.55; P = .0004). Among those with TAA, a surgical inter-
vention was performed on day of admission in 62.1% of
weekday admissions vs 34.9% of weekend admissions (P <
.0001). This difference was much smaller among those with
an aortic aneurysm; 79.6% had a surgical intervention on
day of admission on a weekday vs 77.2% on the weekend (P
< .0001).
Conclusions: Weekend admission for ruptured aortic
aneurysm is associated with an increased mortality com-
pared with admission on a weekday, and this is likely due to
several factors including a delay in prompt surgical inter-
vention.Retrograde pedal access for patients with critical limb
ischemia
Hernan A. Bazan, Linda Le, Melissa Donovan, Tara Sidhom,
Taylor A. Smith, W. Charles Sternbergh
Objective: Retrograde pedal access may allow the treat-
ment of tibial occlusive lesions when standard endovascular
techniques fail. We aimed to analyze the outcomes in
patients with chronic limb ischemia (Rutherford class IV and
V) who were not surgical candidates for a tibial bypass and
had undergone an unsuccessful attempt at revascularization
through an antegrade access.
Methods: During a 3-year period, a retrograde pedal access
was selectively chosen when a popliteal or tibial lesion could
not be crossed through an antegrade approach. Retrogradepedal access was performed under ultrasound guidance
using a 4F micropuncture coaxial sheath. All interventions
were performed in a sheathless fashion using a 0.014- or
0.018-inch â barebackâ wire as support for a 2- or 2.5-mm
balloon angioplasty catheter to cross and treat tibial chronic
total occlusions that could not be treated through an ante-
grade approach. Routine anticoagulation and dual-anti-
platelet therapy were used periprocedurally. Antegrade
access was used to treat any lesion that required a stent
placement after the retrograde wire was snared and brought
through the antegrade guidecatheter. Patient indications and
comorbidities were recorded. Outcomes analyzed were limb
salvage rate, periprocedural complications, and mortality.
Mean and standard deviations were calculated. The Kaplan-
Meier method was used to calculate limb salvage rates.
Results: A review of the 681 lower extremity angiograms in
which a patient had an intervention from July 2010 through
December 2013 identiﬁed 13 patients (nine men) in whom
a retrograde pedal access was performed (mean age, 71.4
 12.4 years). Among these, diabetes was present in 10 of
13 (77%) and chronic renal insufﬁciency (stages II-V) in nine
(69%). Five (38%) had undergone contralateral amputation.
Indications for a retrograde pedal revascularization were
Rutherford chronic limb ischemia class IV in two (15%) and
class V in 11 (85%). Technical success rate was 69% (nine of
13). A variety of popliteal (two of 13) and tibial (13 of 13)
vessels were treated with angioplasty alone (10 of 13) or
angioplasty/stent placement (three of 13) through a retro-
grade approach. The technical failures were due to inability
to cross the occlusion(s). Periprocedurally, there was one
myocardial infarction but no local complications, worsening
renal insufﬁciency, or deaths. At a mean follow-up of 17.1 
10.3 months, the limb salvage rate was 77% (10 of 13).
There was a high mortality rate of 23% (three of 13) on
follow-up in this cohort, occurring at median 6  4 months.
Conclusions: Retrograde pedal access for limb salvage in
high-risk patients is feasible and safe, with acceptable limb
salvage rates at intermediate follow-up. Appropriate can-
didates are those who have failed an antegrade inter-
vention and are poor candidates for a tibial bypass. Future
studies should test whether this mode of revascularization
has favorable limb salvage rates in larger patient pop-
ulations and seek to identify speciﬁc patient populations
who will beneﬁt from this technique.Anatomic ﬁndings and outcomes associated with upper
extremity arteriography and selective thrombolysis for
acute ﬁnger ischemia
Arsalla Islam, Colston Edgerton, Jeanette M. Stafford,
Andrew Koman, Zhongyu Li, Beth P. Smith, Matthew S.
Edwards, Matthew A. Corriere
Objective: Limited evidence exists to guide clinical manage-
ment of acute ﬁnger ischemia (AFI). To further inform diag-
nostic evaluation and decisionmaking, we evaluated anatomic
ﬁndings, procedural management, and amputation-free sur-
vival in an institutional cohort of patients with AFI.
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upper extremity angiography for AFI were identiﬁed. Clinical,
laboratory, and procedural data were collected retrospectively
from medical records, and arteriograms were reviewed to
characterize anatomic ﬁndings. Telephone interviews were
used to determine long-term outcomes, and additional
symptomatic assessments (Symptom Severity and Functional
Status scale, the Cold Sensitivity Severity scale, and the McGill
Pain Severity Scale) were available in a subgroup of patients.
Outcomes included anatomic ﬁndings, use of thrombolysis,
complications, and amputation-free survival. Descriptive sta-
tistics and survival analysis were used to evaluate results.
Results: Thirty-ﬁve patients (54% women) were analyzed
with a median follow-up of 13.7 months. Symptom duration
at time of presentation ranged from 1 to 28 days, and seven
patients had tissue loss or gangrene, or both. Mean age was
47.7  12.2 years. Baseline characteristics included smoking
in 22 (65%), connective tissue disorder in 11 (31%), and his-
tory of repetitive hand trauma in 10 (29%).Themost frequent
anatomic location of arterial pathology identiﬁed during
angiography was distal to the wrist (n = 32), including eight
ulnar/radial aneurysms; upper arm (n = 3) and forearm (n = 8)
lesions were less common. Sixteen patients were treated
with catheter-directed thrombolysis, of which eight (50%)
had interval anatomic improvement on repeat angiography.
Procedure-related adverse events associated with angiog-
raphy included bleeding (n = 3) and pseudoaneurysm (n = 1).
Eleven of 35 patients had subsequent surgical revasculari-
zation at a median of 15 days after angiography. Estimated
(standard error) amputation-free survival was 0.88 (0.07) at 1
month and 0.84 (0.08) at 6 months among patients without
tissue loss or gangrene. Estimated 60-day amputation-free
survival was 0.84 (standard error, 0.08). Overall amputation-
free survival was similar between patients managed with vs
without thrombolysis (P = .61), but subgroup analysis of
those patients without tissue loss or gangrene at the time of
presentation revealed a trend toward improved amputation-
free survival with use of thrombolysis, with 60-day amputa-
tion-free survival of 0.92 vs 0.75 (P = .12). Persistent late
symptoms were present in 17 patients (48.6%) at the last
follow-up and were generally characterized as mild by func-
tional and pain scale assessments.
Conclusions: Angiography performed for AFI frequently
identiﬁes distal occlusive disease, and catheter-directed
thrombolysis may expand revascularization options in select
patients.Closure technique after carotid endarterectomy inﬂuences
local hemodynamics
Gareth J. Harrison, Thien V. How, Robert J. Poole, John A.
Brennan, Jagjeeth B. Naik, S. Rao Vallabhaneni, Robert K.
Fisher
Background: Meta-analysis supports patch angioplasty after
carotid endarterectomy (CEA); however, studies indicate
considerable variation in practice. The hemodynamic effect
of a patch is unclear and this study attempted to elucidate
this and guide patch width selection.
Methods: Four groups were selected: healthy volunteers
and patients undergoing CEA with primary closure, trimmed
patch (5 mm), or 8-mm patch angioplasty. Computer-gen-
erated three-dimensional models of carotid bifurcations
were produced from transverse ultrasound images recorded
at 1-mm intervals. Rapid prototyping generated models for
ﬂow visualization studies. Computational ﬂuid dynamic
studies were performed for each model and validated by
ﬂow visualization. Mean wall shear stress (WSS) and oscil-
latory shear index (OSI) maps were created for each model
using pulsatile inﬂow at 300 mL/min. WSS of <0.4 Pa and
OSI >0.3 were considered pathological, predisposing to
accretion of intimal hyperplasia. The resultant WSS and OSI
maps were compared.
Results: The four groups comprised 8 normal carotid
arteries, 6 primary closures, 6 trimmed patches, and seven
8-mm patches. Flow visualization identiﬁed ﬂow separation
and recirculation at the bifurcation increased with a patch
and was related to the patch width. Computational ﬂuid
dynamic identiﬁed that primary closure had the fewest
areas of low WSS or elevated OSI but did have mild com-
mon carotid artery stenoses at the proximal arteriotomy
that caused turbulence. Trimmed patches had more regions
of abnormal WSS and OSI at the bifurcation, but 8-mm
patches had the largest areas of deleteriously low WSS and
high OSI. Qualitative comparison among the four groups
conﬁrmed that incorporation of a patch increased areas of
low WSS and high OSI at the bifurcation and that this was
related to patch width.
Conclusions: Closure technique after CEA inﬂuences the
hemodynamic proﬁle. Patching does not appear to generate
favorable ﬂow dynamics. However, a trimmed 5-mm patch
may offer hemodynamic beneﬁts over an 8-mm patch and
may be the preferred option.
